Introduction to Declare Timi 58 Commentary
If you are looking for information about Declare Timi 58 Commentary, you have come to the right place. Eric Peterson, MD, chair of the program committee for Scientific Sessions 2018,
Declare Timi 58 Commentary Comprehensive Overview
Prof Stephen D. Wiviott discusses the Stephen D. Wiviott, MD, principal investigator, summarizes the results of the DECLARE
Stephen Wiviott, MD, a senior investigator of the
Summary & Highlights for Declare Timi 58 Commentary
- Dapagliflozin vs Placebo in cardiovascular and kidney outcomes.
- Dr. Stephen Wiviott, Senior Investigator of the
- Stephen Wiviott, MD, discusses a few of the strengths and limitations important for interpreting the results of this trial of ...
- Results of the DELCARE-
- Prof Itamar Raz (Hadassah Hebrew University Hospital, Jerusalem, IL) discuss
We hope this detailed breakdown of Declare Timi 58 Commentary was helpful.
